Symmetry Medical Inc. (Symmetry) is a medical device solutions company, including surgical instruments, orthopedic implants, and sterilization cases and trays. The Company designs, develops and offers worldwide production and supply chain capabilities for these products to customers in the orthopedic industry, and other medical device markets (including but not limited to arthroscopy, dental, laparoscopy, osteobiologic, and endoscopy segments). It also manufactures specialized non-healthcare products, primarily in the aerospace industry. The Company operates in two segments: original equipment manufacturer (OEM) solutions and symmetry surgical. On August 15, 2011, the Company acquired PSC Industries, Inc's Olsen Medical division. On December 29, 2011 it acquired the surgical instruments product portfolio from Codman & Shurtleff, Inc., a Johnson & Johnson Company.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Health Care Equipment & Supplies
- Sub-Industry: Health Care Equipment
- Symbol: NYSE:SMA
- CUSIP: 87154620
- Web: N/A
- 50 Day Moving Avg: $716.00
- 200 Day Moving Avg: $677.00
- Trailing P/E Ratio: N/A
- P/E Growth: 0
Frequently Asked Questions for Symmetry Medical (NYSE:SMA)
What is Symmetry Medical's stock symbol?
Symmetry Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "SMA."
How were Symmetry Medical's earnings last quarter?
Symmetry Medical Inc. (NYSE:SMA) released its quarterly earnings data on Thursday, October, 30th. The company reported $0.13 EPS for the quarter, missing the consensus estimate of $0.15 by $0.02. The company earned $95.90 million during the quarter, compared to the consensus estimate of $98.24 million. The business's quarterly revenue was up .2% compared to the same quarter last year. During the same period last year, the firm earned $0.08 EPS. View Symmetry Medical's Earnings History.
Who are some of Symmetry Medical's key competitors?
Some companies that are related to Symmetry Medical include Partnership Assurance Group PLC (PA), GlaxoSmithKline plc (GSK), AstraZeneca plc (AZN), Merck KGaA (MKGAY), Shire PLC (SHP), Hospira (HSP), Smith & Nephew plc (SN), Omnicare (OCR), ConvaTec Group PLC (CTEC), Mediclinic International PLC (MDC), Health Net (HNT), Patheon NV (PTHN), NMC Health PLC (NMC), Catalent (CTLT), Cotiviti Holdings (COTV), Puma Biotechnology (PBYI), Hikma Pharmaceuticals Plc (HIK) and WuXi PharmaTech (Cayman) (WX).
How do I buy Symmetry Medical stock?
Shares of Symmetry Medical can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Symmetry Medical's stock price today?
MarketBeat Community Rating for Symmetry Medical (NYSE SMA)MarketBeat's community ratings are surveys of what our community members think about Symmetry Medical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Symmetry Medical stock can currently be purchased for approximately $1.50.
Consensus Ratings for Symmetry Medical (NYSE:SMA) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for Symmetry Medical (NYSE:SMA)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for Symmetry Medical (NYSE:SMA)Earnings History by Quarter for Symmetry Medical (NYSE SMA)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|10/30/2014||Q3||$0.15||$0.13||$98.24 million||$95.90 million||View||Listen|
|8/4/2014||Q2||$0.12||$0.17||$98.38 million||$101.30 million||View||Listen|
|5/1/2014||Q1||$0.09||$0.09||$99.10 million||$101.30 million||View||Listen|
|2/20/2014||Q413||$0.08||$0.10||$101.50 million||$101.20 million||View||Listen|
|10/31/2013||Q313||$0.07||$0.08||$99.05 million||$98.00 million||View||Listen|
|8/1/2013||Q2 2013||$0.08||$0.09||$99.01 million||$101.90 million||View||Listen|
|5/2/2013||Q1 2013||$0.15||$0.06||$106.04 million||$98.90 million||View||Listen|
|2/21/2013||Q4 2012||$0.18||$0.17||$107.81 million||$106.60 million||View||Listen|
|11/1/2012||Q312||$0.15||$0.18||$104.33 million||$100.90 million||View||N/A|
Earnings Estimates for Symmetry Medical (NYSE:SMA)
Current Year EPS Consensus Estimate: $-0.01 EPS
Dividend History for Symmetry Medical (NYSE:SMA)
No dividend announcements for this company have been tracked by MarketBeat.com
Headline Trends for Symmetry Medical (NYSE:SMA)
Latest Headlines for Symmetry Medical (NYSE:SMA)
Symmetry Medical (SMA) Chart for Friday, July, 28, 2017